MedTrace Logo

Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin

NCT05729425 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2023-08-18

No results posted yet for this study

Summary

This study evaluates the accuracy of a new ultrasound technology called microvessel imaging for detecting the extent of disease among patients with angiosarcoma of the skin. Microvessel ultrasound imaging uses high frequency waves to visualize vessels in the skin that are not easily seen using other imaging tests.

Conditions

  • Skin Angiosarcoma

Interventions

DEVICE

Ultrasound Microvessel Imaging

Undergo microvessel ultrasound imaging

Sponsors & Collaborators

Principal Investigators

  • Tiffany M Sae-Kho · Mayo Clinic in Rochester

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-08-15
Completion
2023-08-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05729425 on ClinicalTrials.gov